Myriant pulls plug on $125 mln IPO – Fortune

Fortune reported that Myriant has withdrawn its planned $125 million IPO. The publication said that no reasons were given. Based in Quincy, Mass., Myriant is a biochemical company. Its backers include Plainfield Asset Management and PTT Chemical International.

Leave a Reply

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget